From rising shipping and energy costs to disruptions in the sourcing of raw materials and active pharmaceutical ingredients, how vulnerable is Malaysia’s pharmaceutical manufacturing sector the impact of the Middle East war? We speak to the Malaysian Organisation of Pharmaceutical Industries about the pressures local manufacturers are facing,  and what this could mean for medicine supply, costs, and the resilience of the healthcare system.

Image credit: Shutterstock

See omnystudio.com/listener for privacy information.